http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-40590-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e9445e5e3626f36e932c6451a928250
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-04
filingDate 1975-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1979-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IE-40590-B1
titleOfInvention A new 1-phenoxy-3-isopropylamino-2-propanol and processes for the production thereof
abstract 1470039 Alkanolamines CIBA-GEIGY AG 6 Feb 1975 [8 Feb 1974] 5080/75 Heading C2C (L) - 1 - (4 - Hydroayphenoxy) - 2 - hydroxy- 3-isopropylaminopropane and its salts are prepared by standard methods, e.g. resolution or removal of O and/or N protecting group(s), optionally followed by salt formation. The preparation of 4-(2,3-epoxypropoxy)- phenyl - # - D - glucopyranoside, 1 - [p - (#- D - glucopyranosidyloxy)phenoxy] - 3 - isopropylamino - 2 - propanol, 1,2 - O - isopropylidene- 6 - O - (4 - benzyloxyphenyl) - α - D - glucofuranose, 6 - O - (4 - benzyloxyphenyl) - D - glucose, 1 - (4 - benzyloxyphenoxy) - 2S,3 - dihydroxypropane, 1 - (4 - benzyloxyphenoxy) - 2R - hydroxy - 3 - p - tosyloxypropane and 1 - isopropylamino - 2S - hydroxy - 3 - (4 - benzyloxyphenoxy)- propane and its hydrochloride is described. The above compounds may be used for the treatment of myocardial insufficiency, in the form of pharmaceutical preparations containing them in association with a carrier.n[GB1470039A]
priorityDate 1974-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88817670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425970581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413580202
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3123920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048

Total number of triples: 26.